Cargando…
Posterior reversible encephalopathy syndrome in patients with COVID-19
OBJECTIVE: To report four patients with coronavirus disease 2019 (COVID-19) who developed posterior reversible encephalopathy syndrome (PRES). METHODS: Patient data was abstracted from medical records at Weill Cornell Medical Center. RESULTS: Four patients with SARS-CoV-2 infection and PRES were ide...
Autores principales: | Parauda, Sarah C., Gao, Virginia, Gewirtz, Alexandra N., Parikh, Neal S., Merkler, Alexander E., Lantos, Joshua, White, Halina, Leifer, Dana, Navi, Babak B., Segal, Alan Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347314/ https://www.ncbi.nlm.nih.gov/pubmed/32679347 http://dx.doi.org/10.1016/j.jns.2020.117019 |
Ejemplares similares
-
Posterior Reversible Encephalopathy Syndrome
por: Gewirtz, Alexandra N., et al.
Publicado: (2021) -
Long‐term risk of seizure after posterior reversible encephalopathy syndrome
por: Seitz, Alison, et al.
Publicado: (2023) -
Missed cerebrovascular events during prolonged sedation for COVID-19 pneumonia
por: Bruce, Samuel S., et al.
Publicado: (2021) -
Clinical Features and Outcomes of Patients with Posterior Reversible Encephalopathy Syndrome
por: Kalaiselvan, M. S., et al.
Publicado: (2017) -
Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome)
por: Yashi, Kanica, et al.
Publicado: (2023)